Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pyridoxal is one of the three natural forms of vitamin B6, alongside pyridoxine and pyridoxamine. It is a precursor to pyridoxal phosphate, the active coenzyme form that plays a crucial role in numerous biochemical reactions. Pyridoxal phosphate acts as a coenzyme in amino acid metabolism (including transamination, decarboxylation, and deamination), glycogen breakdown, synthesis of neurotransmitters (such as serotonin, dopamine, norepinephrine, GABA), sphingolipid biosynthesis, nucleic acid synthesis, and hemoglobin production. Pyridoxal itself is used primarily for nutritional supplementation or to treat dietary deficiencies or imbalances[1][3][6]. Its mechanism of action involves conversion to pyridoxal phosphate by cellular kinases; this active form then participates directly in enzymatic processes essential for normal metabolic function[1][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pyridoxal.